X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4327) 4327
Patent (623) 623
Publication (481) 481
Conference Proceeding (308) 308
Newspaper Article (161) 161
Book Chapter (123) 123
Paper (65) 65
Book / eBook (62) 62
Book Review (57) 57
Dissertation (47) 47
Magazine Article (38) 38
Web Resource (32) 32
Reference (8) 8
Report (7) 7
Technical Report (4) 4
Government Document (2) 2
Data Set (1) 1
Newsletter (1) 1
Trade Publication Article (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (709) 709
index medicus (539) 539
female (490) 490
physics (392) 392
human necessities (377) 377
male (377) 377
adult (362) 362
hygiene (308) 308
medical or veterinary science (305) 305
animals (270) 270
chemistry (262) 262
middle aged (257) 257
metallurgy (219) 219
analysis (213) 213
preparations for medical, dental, or toilet purposes (206) 206
nuclear experiment (192) 192
physics, nuclear (190) 190
agriculture (170) 170
aged (159) 159
oncology (152) 152
research (146) 146
forestry (144) 144
organic chemistry (140) 140
trapping (138) 138
animal husbandry (137) 137
fishing (137) 137
biocides, e.g. as disinfectants, as pesticides, as herbicides (136) 136
hunting (136) 136
pest repellants or attractants (136) 136
plant growth regulators (136) 136
preservation of bodies of humans or animals or plants or partsthereof (136) 136
ecology (131) 131
specific therapeutic activity of chemical compounds ormedicinal preparations (128) 128
surgery (126) 126
adolescent (122) 122
electricity (111) 111
young adult (104) 104
cancer (100) 100
article (99) 99
neurosciences (95) 95
microbiology (92) 92
plant sciences (92) 92
general tagging of cross-sectional technologies spanning over several sections of the ipc (88) 88
general tagging of new technological developments (88) 88
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (88) 88
[ phys.nexp ] physics [physics]/nuclear experiment [nucl-ex] (87) 87
environmental sciences (87) 87
neutrons (87) 87
diagnosis (86) 86
physics, particles & fields (86) 86
biochemistry & molecular biology (85) 85
heterocyclic compounds (85) 85
breast cancer (84) 84
treatment outcome (84) 84
plants (83) 83
hematology (82) 82
nucleosynthesis (82) 82
technologies or applications for mitigation or adaptation againstclimate change (82) 82
time factors (82) 82
astrophysics (80) 80
physics, multidisciplinary (80) 80
women (80) 80
pregnancy (78) 78
counting (77) 77
evolution (77) 77
biochemistry (76) 76
prospective studies (76) 76
calculating (74) 74
computing (74) 74
health aspects (73) 73
model (73) 73
radiation therapy (72) 72
instruments & instrumentation (70) 70
medicine & public health (70) 70
care and treatment (69) 69
electric digital data processing (68) 68
identification (68) 68
substance abuse (68) 68
nuclear science & technology (65) 65
physical sciences (65) 65
risk factors (65) 65
beer (64) 64
electrotherapy (64) 64
magnetotherapy (64) 64
ultrasound therapy (64) 64
cross sections (62) 62
prognosis (62) 62
enzymology (61) 61
mutation or genetic engineering (61) 61
spirits (61) 61
vinegar (61) 61
wine (61) 61
enzymes (60) 60
aged, 80 and over (59) 59
basic electric elements (59) 59
capture (59) 59
expression (59) 59
fysik (59) 59
isotopes (59) 59
nuclear physics (59) 59
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (28) 28
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Gerstein Science - Stacks (6) 6
UofT at Mississauga - Stacks (6) 6
St. Michael's College (John M. Kelly) - 3rd Floor (5) 5
Art - Library use only (4) 4
Trinity College (John W Graham) - Stacks (4) 4
UTL at Downsview - May be requested (4) 4
UofT at Scarborough - Stacks (4) 4
Mathematical Sciences - Stacks (3) 3
Knox College (Caven) - Stacks (2) 2
Online Resources - Online (2) 2
Pontifical Inst. Mediaeval Studies - Library use only (2) 2
Regis College - Storage (2) 2
Royal Ontario Museum - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Media Commons - Audio Visual (1) 1
Music - Reference (1) 1
Music - Stacks (1) 1
Regis College - Stacks (1) 1
Robarts - May be requested in 6-10 wks (1) 1
Robarts - Protected Material (1) 1
St. Augustine's Seminary - Stacks (1) 1
UofT at Scarborough - May be requested in 6-10 wks (1) 1
UofT at Scarborough - Withdrawn (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5212) 5212
German (379) 379
French (241) 241
Spanish (40) 40
Chinese (38) 38
Korean (17) 17
Portuguese (17) 17
Japanese (11) 11
Latin (6) 6
Dutch (5) 5
Hungarian (4) 4
Italian (4) 4
Russian (4) 4
Danish (3) 3
Ukrainian (2) 2
Ancient Greek (1) 1
Croatian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer
Journal Article